D1/3-MAGE-3-His fusion protein

BIOLOGICAL2 trials

Sponsors

SWOG Cancer Research Network, European Organisation for Research and Treatment of Cancer - EORTC

Conditions

Melanoma (Skin)

Phase 2

Vaccine Therapy in Treating Patients With Stage IV Melanoma

CompletedNCT00042783

SWOG Cancer Research NetworkMelanoma (Skin)

Start: 2002-09-30End: 2006-03-31Updated: 2013-06-24

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

European Organisation for Research and Treatment of Cancer - EORTCMelanoma (Skin)

Start: 2004-05-31Updated: 2015-02-10